Background: WHO has declared COVID-19 infection as a health emergency of international concern on 11thMarch, 2020. It is not clear whether clinical characteristics of pregnant women with COVID-19 differ from those of nonpregnant women and whether it aggravates COVID-19 symptoms and whether antiviral therapy is necessary for COVID-19 infected pregnant women.
Methods: This is a prospective study of 47 cases based on the compiled clinical data for pregnant women with COVID-19 from April 2020 to October 2020. A laboratory confirmed positive case of COVID-19 infection in pregnant women were included.
Results: In the study involving 47 pregnant patients with covid-19 infection, 38(81%) had cough, 20(42.5%) reported fever, 12(25.5%) had diarrhea, followed by 10(21%), 8(17%) and 3(6%) experienced sore throat,myalgia and dyspnea,respectively. 9(19%) out of 47 were asymptomatic and were tested in view of strong history of contact with covid infected patients. With 32 of 47 (68%) delivered through LSCS for obstetric indication and 15(32%) delivered vaginally.40 (85%) patients were of term gestation and 7(15%) were from preterm gestational age. Conclusions: At present, there is no evidence regarding the greater risk of pregnant women to succumb to COVID-19 infection and experience severe pneumonia. This preliminary study however does not rule out the possibility of vertical transmission of SARS-CoV- 2 when it manifests towards the end of pregnancy.
Keywords: COVID-19, Pregnancy, Pandemic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.